| S.No. | Title of Project and Sanction Letter No | Sponsor / Funding Agency | Sanctioned Amount (Rs. in Lakhs) | Tenure / Duration | Supervisor / Principal Investigator / Co-Supervisor | Number of Manpower / Research Fellows | Brief Objective |
|---|---|---|---|---|---|---|---|
| In-Progress | |||||||
| 1. | Development of gold nanoparticles based lateral flow immunoassay for rapid and early detection of novel biomarker microRNA-204 in type 1 diabetes (T1D) 17X/adhoc/69/2022-ITR | ICMR | 1751633 | three years | Dr Ravi Partap Barnwal / Dr Gurpal Singh | 1 | To improve the efficacy of the existing treatment |
| 2. | Development of peptide mediated antisense oligonucleotide (PMAsO) based next generation therapeutics for priority pathogens R/12020/02/2024-HR | Department of Health Research Ministry of Health and Family Welfare | 4380000 | three years | Dr Ravi Partap Barnwal / Dr Gurpal Singh | 1 | To improve the efficacy of the existing treatment |
| 3. | CSR funds for carrying out the various research work involved in pharmaceuticals 03042024 | Financial Assistance under CSR funds for carrying out the various research work involved in pharmaceuticals at Panjab University | 3740000 | three years | Dr Amita Sarwal / Dr Amita Sarwal | 1 | To improve the efficacy of the existing treatment |
| 4. | "DNA Aptamer based sirtuin-I nanoformulation in the management of iron deficiency anemia EMDR/SG/14/2023-0940 | ICMR | 1542000 | three years (2.2.2024 to 1.2.2027) | Dr Ravi Partap Barnwal / Dr Gurpal Singh | 0 | To improve the efficacy of the existing treatment |
| 5. | Development of new chemo-immunotherapy approach for colorectal cancer SERB/F/9462/2023-2024 | SERB | 2999830 | three years | Professor Nitin Bansal / Professor Kanwaljit Chopra | 0 | To improve the efficacy of the existing treatment |
| 6. | Aptamer conjugated Teriparatide loaded PLGA/PHBV nanocarriers mediated delivery coners an effective treatment for osteoporosis 2023 | DHR | 60.00 | 36 | Prof. Sanjay K Bhadada / Dr Ravi Pratap Barnwal and Dr Gurpal Singh | 1 | A novel targeted treatment and it development for osteoporosis patients |
| 7. | VirusInspired peptide design of monomeric pseudo-alpha helix for the recognition of its RNA targets 2023 | CSIR | 45.00 | 36 | Dr Ravi Pratap Barnwal / Dr Gurpal Singh | 1 | Development of pseudo helix peptide for different RNAs. |
| 8. | A fluorescent cyclic peptide conjugated amphipathic-D diastereomers nanotherapeutics for an early detection and treatment of prostate cancer CRG/2022/000628 | DST-SCIENCE & ENGINEERING RESEARCH BOARD (SERB) | 60.00 | Three years | Dr Gurpal Singh / Dr Ravi Pratap Barnwal | 1 | This project is particularly focusing on early stage detection and treatment of prostate cancer |
| 9. | Development of new chemo-immunotherapy approach for colorectal cancer CRG/2022/003884 | SERB-CRG | 59.00 | 36 | Professor Kanwaljit Chopra / Dr. Sandip V. Pawar | 1 | Despite advances in cancer therapy employing chemo, immuno and radiotherapy, nonsignificant reduction in mortality and relapse rate have remained a major challenge. Very recently, a promising approach of chemo-immunotherapy is being explored wherein the potential synergism of two gating strategies will be harnessed to achieve a much robust therapeutic response. The main objective of our study is to elucidate the role of indigenously synthesized novel toll like receptor (TLR)7 / 8 agonists in combination with traditional chemotherapeutic agents in in-vitro and in-vivo models of colorectal cancer along-with biochemical, molecular, genetic and histopathological biomarkers elucidation. The findings will substantiate the role of TLR-7 and 8 as novel targets for chemo-immunotherapy. These compounds can be further translated in to the clinics. |
| 10. | Aptamer conjugated QDs based fluorescence technique for rapid detection of Lead in drinking ground and surface water 2022 | DST-UT | 2.00 | 12 | Dr Ravi Pratap Barnwal / Dr Gurpal Singh | 1 | Rapid method development for the detection of Lead |
| 11. | Development of gold nanoparticles based lateral flow immunoassay for rapid and early detection of novel biomarker microRNA-204 in type 1 diabetes (T1D) 2022 | ICMR | 55.50 | 36 | Dr Ravi Pratap Barnwal / Dr Gurpal Singh | 1 | Lateral flow technology will be developed for early stage detection of type 1 diabetes |
| 12. | API and Intermediate Synthesis 2022 | Valence Labs Pvt Ltd. | 111.00 | 60 | Professor Ranju Bansal / Dr Ashok Yadav | 3 | The objective of the project is development of low cost improved process of some selected APIs and their key intermediates by adopting new synthetic routes. |
| 13. | SalFluSENSOR: Fluorescence based nanobiosensor design for rapid and specific detection of Salmonella and Influenza 2021 | DHR | 30.00 | 36 | Dr Ravi Pratap Barnwal / Dr Gurpal Singh | 1 | Fluorescence based nanobiosensor will be designed for early stage detection of salmonella and influenza pathogens |
| 14. | Development of nanoinhibitor against CssA RNA thermometer from Neisseria meningitis 2022 | ICMR | 10.00 | 24 | Dr Ravi Pratap Barnwal / Dr Gurpal Singh | 1 | To develop inhibitors for Neisseria meningitis |
| 15. | Identification and Characterization of Downstream Effector Proteins for Gao, the Major Neural G protein in Brain Tissue 2020 | DBT | 61.00 | 36 | Dr Santosh Kumar / Dr Ravi Pratap Barnwal and Dr Gurpal Singh | 1 | Here identification and characterization of downstream effector proteins for Gao will be explored |
| 16. | Development and evaluation of fish oil - probiotic supplemented composite dressing for chronic wounds CRG/2019/002768 | DST-SCIENCE & ENGINEERING RESEARCH BOARD (SERB) | 44.44 | 36 | Professor Indu Pal Kaur / Dr Parneet Kaur Deol | 1 | Development and evaluation of fish oil - probiotic supplemented composite dressing for chronic wounds |
| 17. | Biohybrid antisense PNA-graphene QD stargeting bcl-2 gene for cancer theranostic BMS/Adhoc/15/2020-21 | ICMR | 38.00 | 3 year 5 months | Dr Gurpal Singh / Dr Ravi Pratap Barnwal | 1 | A photosensor will be developed for rapid deduction of early stage breast cancer and their treatment |
| 18. | Liposomal Technology Platform 61/UIPS/OPK | BDH Industries Pvt Ltd, Mumbai | 4.93 | 36 | Professor O.P. Katare / Dr Gurpal Singh | 1 | Liposomal Technology Platform |
Enquiry No(s): 1800-180-2065, +91 172 2534818, 2534866 (from 9:30 am to 1:00 pm & 2:30 pm to 5:00 pm on working days )
© 1997- 2026 - Panjab University, Chandigarh, India. Developed by: Computer Centre, Panjab University | Disclaimer